Keywords | Study Title | Status |
| AMD3100, Peripheral Blood Stem Cells, Transplantation, RP124 | Compassionate Use Protocol for the use of AMD3100 to Mobilize Peripheral Blood Stem Cells for Collection and Transplantation | Open to Enrollment |
| Pediatric Leukemia, Myelodysplasia, Umbilical Cord Blood (UCB Transplantation, RP127 | Multi-center, Open Label, Randomized Trial Comparing Single versus Double Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients with Leukemia and Myelodysplasia | Open to Enrollment |
| Marrow Transplantation, HLA-Matched Family Members, Severe Aplastic Anemia, RP128 | Cyclophosphamide and Antithymocyte Globulin Conditioning Regimen for Marrow Transplantation from HLA-Matched Family Members for Severe Aplastic Anemia: Effect of Marrow Cell Dose on Chronic Graft-vs.-Host Disease: A Multi-Center Trial | Open to Enrollment |
| Allogeneic Stem Cell Transplantation, Myelofibrosis, RP129 | Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis | Open to Enrollment |
| Randomized Trial, Prophylaxis, Hematopoietic StemCell Transplantation, Relapsed ALL, RP130 | A Randomized Trial of Sirolimus-Based Graft versus Host Disease Prophylaxis after Hematopoietic Stem Cell Transplantation in Relapsed ALL | Open to Enrollment |
| Unrelated bone marrow transplant, unrelated stem cell transplant, allogenetic transplant | Development of a National Marrow Donor Program (NMDP) Research Database for Unrelated Stem Cell Transplantion | Open to Enrollment |
| Unrelated bone marrow transplant, unrelated stem cell transplant, allogenetic transplant | National Marrow Donor Program (NMDP) Research Sample Depository for Unrelated Stem Cell Transplantation Research | Open to Enrollment |
| Stem cell transplantation, bone marrow donation | A phase III randomized, multicenter trial comparing G-CSF mobilized peripheral blood stem cell with marrow transplantation from HLA compatible unrelated donors | Open to Enrollment |
| Unrelated matched siblings, patients with hematologic malignancies, GVHD, unrelated stem cell transplant | Study to determine the most promising postgrafting immunosuppression for prevention of acute GVHD after unrelated donor G-CSF mobilized peripheral blood monuclear stem cell transplantation | Open to Enrollment |
| AML >55, Related sibling donors (MRD) | Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation from HLA Matched Related Donors for Treatment of Older Patients with De Novo or Secondary Acute Myeloid Leukemia in First Complete Remission | Open to Enrollment |
| Patients with low or falling donor T-cell chimerism s/p NMSCT | Pentostatin and donor lymphocyte infusion for low donor t-cell chimerism after hematopoietic cell transplantation using nonmyeloablative conditioning - a mulit -center trial | Open to Enrollment |
| Patients with hematologic malignancies, Allogeneic Bone marrow transplant from HLA-idential sibling donor, single antigen mismatched related or unrelated donor, marrow/PBSC or cord blood available for marrow donation | Rapamyucin for Immunosuppression and B cell Modulation post stem cell transplant for acute lymphoblastic leukemia | Open to Enrollment |
| Patients with hematologic malignancies | Study comparing myeloablative to nonmyeloablative transplant conditioning in patients with myelodyspastic syndrome or acute myelogenous leukemia. A multi-center Phase III Trial. | Open to Enrollment |
| Patients with hematologic malignaicies (related donor), decreased risk of rejection, no BMT within 6-8 months | Comparison of nonmyeloablative conditioning with TBI versus Fludarabine/TBI for HLA-matched related hematopoietic cell transplantation for treatment of hematologic malignancies | Open to Enrollment |
| HLA matched related hematopoetic stem cell transplantation, increased risk of rejection, BMT within 6 months | Study of nonmyeloablative conditioning with TBI or fludarabine/TBI | Open to Enrollment |
| Retrospective Clinical Database | International Blood and Marrow Transplant Registry (IBMTR) and Autologous Bone Marrow Transplant Registry (ABMTR) - Development of outcomes databases | Open to Enrollment |
| Campath, allogeneic transplants with mis-matched related and unrelated donors, RP93 | Campath [Alemtuzumab] Dose Escalation, Low-Dose TBI and Fludarabine Followed by HLA Class I Mismatched Donor Stem Cell Transplantation for Patients with Hematologic Malignancies - A Multi-Center Trial | Open to Enrollment |
| Retrospective Clinical Database, RP126 | Assessment of the Correlation between Pre-transplant Comorbidities and Post-Transplant Outcomes Using the Hematopoietic cell Transplantation-Specific Comorbidity Index (HCT-CI): A Multi-Center Trial | Open to Enrollment |
| Paroxysmal Nocturnal Hemoglobinuria, Hematopoietic Stem Cell, Prion Protein | Role of Prion Protein in Human Hematopoietic Stem Cells | Open to Enrollment |
| Pulmonary Hypertension, Myelofibrosis, Bone Marrow, Scarring, Flolan | Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder | Open to Enrollment |
